Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer

1. Kerns, S.L.
2. Amidon Morlang, A.
3. Lee, S.M.
4. Peterson, D.R.
5. Marples, B.
6. Zhang, H.
7. Bylund, K.
8. Rosenzweig, D.
9. Hall, W.
10. De Ruyck, K.
11. Rosenstein, B.S.
12. Stock, R.G.
13. Gómez-Caamaño, A.
14. Vega, A.
15. Sosa-Fajardo, P.
16. Taboada-Valladares, B.
17. Aguado-Barrera, M.E.
18. Parker, C.
19. Veldeman, L.
20. Fonteyne, V.
21. Bultijnck, R.
22. Talbot, C.J.
23. Symonds, R.P.
24. Johnson, K.
25. Rattay, T.
26. Webb, A.
27. Lambrecht, M.
28. de Ruysscher, D.
29. Vanneste, B.
30. Choudhury, A.
31. Elliott, R.M.
32. Sperk, E.
33. Herskind, C.
34. Veldwijk, M.R.
35. Rancati, T.
36. Avuzzi, B.
37. Valdagni, R.
38. Azria, D.
39. Farcy Jacquet, M.-P.
40. Chang-Claude, J.
41. Seibold, P.
42. West, C.
43. Janelsins, M.
44. Chen, Y.
45. Messing, E.
46. Morrow, G.
47. Briers, E.
48. Dunning, A.
49. Gutiérrez-Enríquez, S.
50. Paul Symonds, R.
51. Stobart, H.
52. Ward, T.
53. West, C.M.
54. Show all authors +